Equity · Healthcare
RNA
NASDAQAvidity Biosciences (RNA)
The line runs 12.17 USD on 12 August through 8.37 USD on 9 November, on a scale from 7.5 to 15.0. Days the market did not trade hold the previous close, flat.
- Market cap
- 143.2M USD
- Avg volume
- 17.3K
- Mentions, 30 days
- 2
as of Nov 9, 2026
Have Avidity Biosciences (RNA) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, no Avidity Biosciences insider bought or sold shares on the open market; all 8 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 10 Nov 2026, newest Form 4 filing 18 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Sep 2026 | Younis HusamChief Scientific Officer | Tax withheld | 11,216 | 100K USD |
| 18 Sep 2026 | Hughes Steven GeorgeChief Medical Officer | Tax withheld | 21,459 | 192K USD |
| 18 Sep 2026 | Flanagan W. MichaelDirector | Tax withheld | 22,812 | 204K USD |
| 18 Sep 2026 | Boyce SarahDirector | Tax withheld | 126,418 | 1.1M USD |
| 18 Sep 2026 | Kenney StephanieSee Remarks | Tax withheld | 2,375 | 21K USD |
| 18 Sep 2026 | Gallagher Kathleen P.See Remarks | Tax withheld | 11,632 | 104K USD |
| 18 Sep 2026 | Winslow Brendan R.Chief Financial Officer | Tax withheld | 6,742 | 60K USD |
| 18 Sep 2026 | Hoyos Rocio MartinChief Strategy Officer | Tax withheld | 8,320 | 74K USD |
Which funds hold Avidity Biosciences (RNA)?
7 of the 45 institutional funds we track reported a Avidity Biosciences position for the quarter ended 30 Jun 2026 — a combined 13.9M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Two Sigma Investments | Added | 345,481 | 4.6M USD | +93.5% |
| Millennium Management | Held (±25%) | 200,559 | 2.7M USD | +5.1% |
| AQR Capital Management | New position | 172,235 | 2.3M USD | |
| Tudor Investment Corp | Added | 129,591 | 1.7M USD | +81.6% |
| Balyasny Asset Management | Trimmed | 105,875 | 1.4M USD | −55.0% |
| Citadel Advisors | Trimmed | 67,639 | 910K USD | −38.5% |
| Renaissance Technologies | New position | 14,971 | 201K USD | |
| Marshall Wace | Exited | |||
| Point72 Asset Management | Exited |
What has been filed or recorded for Avidity Biosciences (RNA)?
The filings we hold for Avidity Biosciences, newest first: 4 quarterly earnings reports and 2 reported financial figures, the latest dated 30 Jun 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −1.18 USD | Revenue $3M |
| 30 Jun 2026 | Financials | Total assets | 280.5M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 214.6M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.97 USD | Revenue $20M |
| 30 Jun 2025 | Quarterly earnings | Q2 2026 reported | EPS −0.75 USD | Revenue $4M |
| 31 Mar 2025 | Quarterly earnings | Q1 2026 reported | EPS −0.44 USD | Revenue $2M |
What is Reddit saying about Avidity Biosciences (RNA)?
Reddit mentioned RNA 2 times in the 30 days to 10 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 50% read bullish, 0% bearish and 50% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of Avidity Biosciences (RNA) compare with its price?
Share ↗
Which subreddits are talking about Avidity Biosciences (RNA)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 2 | +0.05 |
What do people ask about Avidity Biosciences (RNA)?
What did Avidity Biosciences shares close at?8.37
Avidity Biosciences closed at 8.37 USD on 9 Nov 2026, unchanged on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Avidity Biosciences’ market cap?143.2M
Avidity Biosciences is worth 143.2M USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
Have Avidity Biosciences insiders bought or sold shares recently?8 filings
In the 90 days to 10 Nov 2026, no Avidity Biosciences insider bought or sold shares on the open market; all 8 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Avidity Biosciences?7 of 45
7 of the 45 funds we track reported a Avidity Biosciences position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, Millennium Management and AQR Capital Management. See Funds
When did Avidity Biosciences last report earnings?−1.18
Avidity Biosciences last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −1.18 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Avidity Biosciences?0 mentions
Avidity Biosciences was mentioned 0 times in the last 7 days across the finance subreddits we track, and 2 times over the trailing 30 days. Of the 2 mentions scored for sentiment, 50% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings